Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2005
10/06/2005US20050222151 Non-Imidazole heterocyclic compounds
10/06/2005US20050222150 6-(p-morpholinoanilino)-4-(4-substituted-1-piperazinyl)-2-(methylthio)pyrimidines having an excellent inhibitory effect on replication of Hepatitis C virus
10/06/2005US20050222149 For therapy of neurodegenerative and/or neurological disorders, e.g., Alzheimer's disease, in a mammal
10/06/2005US20050222147 Process for the preparation of morpholine derivatives and intermediates therefore
10/06/2005US20050222146 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
10/06/2005US20050222145 Cathepsin S inhibitors
10/06/2005US20050222141 N-(2,6-dichlorobenzoyl)-4-[1-methyl-7-(pyrrolidine-1-ylmethyl)-2,4-quinazoline-dione-3-yl]-L-phenylalanine trifluoroacetate; 4 integrin antagonist; antiinflammatory, anticarcinogenic agent, antiallergent; asthma, psoriasis, cardiovascular diseases, arterial sclerosis, restenosis, tumor proliferation
10/06/2005US20050222140 Improved DP-IV inhibitors increase the steady state concentrations of GLP-1 and GIP, resulting in improved glucose tolerance
10/06/2005US20050222139 Non-peptide gnrh antagonists
10/06/2005US20050222124 Benzenesulfonamide derivatives as antipsychotic agents
10/06/2005US20050222118 For therapy of inflammatory or allergic condition
10/06/2005US20050222089 taxane is prepared by esterifying an appropriate baccatin carrying a C-13 hydroxyl functional group with an acid derivative and is obtained by controlled saponification
10/06/2005US20050222056 Heterocyclic compounds and their use in the detection of nucleic acids
10/06/2005CA2560700A1 Tetrahydrocarbazoles and derivatives
10/06/2005CA2560368A1 Compounds for the treatment of diseases
10/06/2005CA2559733A1 Inhibitors of histone deacetylase
10/06/2005CA2559035A1 Substituted heteroaryl- and phenylsulfamoyl compounds
10/06/2005CA2557785A1 Hiv integrase inhibitors
10/05/2005EP1582519A2 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/05/2005EP1581530A1 Indane compounds as ccr5 antagonists
10/05/2005EP1581526A1 Benzisoxazole derivatives useful as inhibitors of protein kinases
10/05/2005EP1581525A2 Compounds having an activity at metabotropic glutamate receptors
10/05/2005EP1581524A2 Oxazolidinones as antibacterial agents
10/05/2005EP1581523A1 PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
10/05/2005EP1581521A1 Fused heterocyclic derivatives as ppar modulators
10/05/2005EP1581518A2 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
10/05/2005EP1581515A1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/05/2005EP1581514A2 Chemical compounds
10/05/2005EP1581509A2 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as edg receptor agonists
10/05/2005EP1581505A1 Pyridazinone derivatives as gsk-3beta inhibitors
10/05/2005EP1581499A1 Microsomal triglyceride transfer protein inhibitors
10/05/2005EP1581492A1 N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
10/05/2005EP1581491A1 Indole derivatives as ppar modulators
10/05/2005EP1581488A1 Inhibitors of tace
10/05/2005EP1581309A2 Kinase modulators
10/05/2005EP1581261A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands
10/05/2005EP1581222A2 COMPOSITIONS AND METHODS FOR INHIBITING TGF-&bgr;
10/05/2005EP1581207A2 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
10/05/2005EP1272168B1 Small organic molecule regulators of cell proliferation
10/05/2005EP0939632B1 NON-PEPTIDYL VASOPRESSIN V1a ANTAGONISTS
10/05/2005CN1678613A Hetereoaryl nitrile derivatives
10/05/2005CN1678609A 2-pyrrolidin-2-yl-[1, 3, 4]-oxadiazole derivatives and their use as anti-depressants
10/05/2005CN1678594A Morpholin-acetamide derivatives for the treatment of inflammatory diseases
10/05/2005CN1678593A Microbiocidal (e.g. fungicidal) 1, 2, 3-triazole derivatives
10/05/2005CN1678589A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them
10/05/2005CN1678578A Indoles having anti-diabetic activity
10/05/2005CN1678320A N-biarylmethyl aminocycloalkanecarboxamide derivatives
10/05/2005CN1678317A 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/05/2005CN1678314A Glycinamide derivatives as raf-kinase inhibitors
10/05/2005CN1678306A -3 (sulfonamidoethyl) -indole derivaties for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
10/05/2005CN1678303A Keto cannabinoids with therapeutic indications
10/05/2005CN1678192A Arthropodicidal anthranilamides
10/05/2005CN1221548C Oxazolidinones having sulfoximine functional group
10/05/2005CN1221547C Linezolid-crystal form II
10/05/2005CN1221537C Epimino substituted benzene derivative
10/05/2005CN1221534C Substited 8-arylquinoline phosphodiesterase-4 inhibitors
10/04/2005US6951940 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders
10/04/2005US6951889 7-acetamidinyl derivatives
10/04/2005US6951878 Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases)
10/04/2005US6951876 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
10/04/2005US6951872 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
10/04/2005US6951863 Pyridoarylphenly oxazolidinone antibacterials, and related compositions and methods
10/04/2005US6951856 Substituted pyrimidine-sulfonamide derivatives are used as endothelin receptor antagonists
10/04/2005US6951851 Substituted pyrazoles
10/04/2005US6951849 Psychological disorders; central nervous system disorders; schizophrenia
10/04/2005CA2257284C Remedy for autoimmune diseases
10/04/2005CA2243706C Azolyl piperazinyl phenyl oxazolidinone antimicrobials
10/04/2005CA2185661C Novel iron chelator and inhibitor of iron-mediated oxidation
09/2005
09/29/2005WO2005090347A1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors
09/29/2005WO2005090340A1 Piperidine-1-carboxamide derivative
09/29/2005WO2005090339A1 New antibacterial agents
09/29/2005WO2005090338A1 Ether derivatives, their manufacture and use as pharmaceutical agents
09/29/2005WO2005090332A1 Substituted quinazoline or pyridopyrimidine derivative
09/29/2005WO2005090330A1 N-piperidine derivates as ccr3 modulators
09/29/2005WO2005090328A1 Heterocyclic compound and use thereof
09/29/2005WO2005090313A1 N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides
09/29/2005WO2005090311A1 Novel heterocyclyl-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
09/29/2005WO2005090300A1 Novel benzyl(idene)-lactam derivatives
09/29/2005WO2005090298A1 Sulphonamide derivatives
09/29/2005WO2005090297A1 Sulphonamide derivatives
09/29/2005WO2005090292A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005089770A1 Benzodiazepines for treating or preventing or preventing rsv infection
09/29/2005WO2005089754A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
09/29/2005WO2005089753A2 Daao inhibiting bξnzisoxazoles and their use for the treatment of mental disorders
09/29/2005WO2005073224A3 Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer
09/29/2005WO2005073195A3 Hcv ns-3 serine protease inhibitors
09/29/2005WO2005054234A3 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy
09/29/2005WO2005046688A3 Methods of use of thrombin receptor antagonists
09/29/2005WO2005035495B1 Fibrinogen receptor antagonists and their use
09/29/2005WO2005012271A3 Process for the synthesis of biaryl oxazolidinones
09/29/2005WO2004089943A8 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues
09/29/2005WO2004084843A3 Inhibitors of cathepsin s
09/29/2005US20050215786 Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,,2,4-triazol-3-one
09/29/2005US20050215785 Reacting methanesulfonyl chloride with 3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxylic acid, reacting with 2-amino-3-methyl-5-chlorobenzoic acid to produce -[3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl]-6-chloro-8-methyl-4H-3,1-benzoxazin-4-one
09/29/2005US20050215784 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
09/29/2005US20050215603 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
09/29/2005US20050215596 Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals
09/29/2005US20050215594 Diabetes, obesity, urogenital disorders, cardiovascular disorders, atherosclerosis; 4-[(2R)-2-(([(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino)methyl)-3,4-dihydro-2H-chromen-6-yl]benzoic acid for example
09/29/2005US20050215587 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions
09/29/2005US20050215577 Tetrahydrocarbazoles and derivatives
1 ... 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 ... 647